| Full Name | Ethan Karle |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 580 Court St, Keene, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114456290 | NPI | - | NPPES |
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, today announced receipt of a $3.6 million annual notice of award for the Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) Grant supporting GeoVax's HIV/AIDS vaccine program.
The Affordable Care Act (ACA, also known as Obamacare) is dramatically changing health care delivery in the U.S. Specific parts of the new law, which will be phased in through 2020, will have a significant impact on patients with diabetes and prediabetes, as explored in a comprehensive Review article published in Diabetes Technology & Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Lifestyle interventions, including physical activity and structured weight loss programs, can result in significant weight loss for overweight, obese and severely obese adults, according to two reports that were posted online today by JAMA. The studies and accompanying editorials were made available early online to coincide with the presentation of these papers at the 28th Annual Scientific Meeting of the Obesity Society. The articles will appear in the October 27 print issue of JAMA.
A new study reveals the mechanism by which a genetic mutation linked with Parkinson's disease (PD) renders dopamine neurons particularly vulnerable to cell injury and death.
On display at this year's Radiological Society of North America (RSNA) annual meeting, Royal Philips Electronics is highlighting its portfolio in the field of interventional radiology/oncology. The company is developing innovative image-guidance technologies for increasing the range and quality of minimally-invasive interventions and therapies.
› Verified 2 days ago
| Entity Name | Cheshire Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093803397 PECOS PAC ID: 1456260165 Enrollment ID: O20070913000090 |
News Archive
GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, today announced receipt of a $3.6 million annual notice of award for the Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) Grant supporting GeoVax's HIV/AIDS vaccine program.
The Affordable Care Act (ACA, also known as Obamacare) is dramatically changing health care delivery in the U.S. Specific parts of the new law, which will be phased in through 2020, will have a significant impact on patients with diabetes and prediabetes, as explored in a comprehensive Review article published in Diabetes Technology & Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Lifestyle interventions, including physical activity and structured weight loss programs, can result in significant weight loss for overweight, obese and severely obese adults, according to two reports that were posted online today by JAMA. The studies and accompanying editorials were made available early online to coincide with the presentation of these papers at the 28th Annual Scientific Meeting of the Obesity Society. The articles will appear in the October 27 print issue of JAMA.
A new study reveals the mechanism by which a genetic mutation linked with Parkinson's disease (PD) renders dopamine neurons particularly vulnerable to cell injury and death.
On display at this year's Radiological Society of North America (RSNA) annual meeting, Royal Philips Electronics is highlighting its portfolio in the field of interventional radiology/oncology. The company is developing innovative image-guidance technologies for increasing the range and quality of minimally-invasive interventions and therapies.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ethan Karle, Po Box 810, Hanover, NH 03755-0810 Ph: (603) 308-1453 | Ethan Karle, 580 Court St, Keene, NH 03431-1718 Ph: (603) 354-5400 |
News Archive
GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, today announced receipt of a $3.6 million annual notice of award for the Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) Grant supporting GeoVax's HIV/AIDS vaccine program.
The Affordable Care Act (ACA, also known as Obamacare) is dramatically changing health care delivery in the U.S. Specific parts of the new law, which will be phased in through 2020, will have a significant impact on patients with diabetes and prediabetes, as explored in a comprehensive Review article published in Diabetes Technology & Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Lifestyle interventions, including physical activity and structured weight loss programs, can result in significant weight loss for overweight, obese and severely obese adults, according to two reports that were posted online today by JAMA. The studies and accompanying editorials were made available early online to coincide with the presentation of these papers at the 28th Annual Scientific Meeting of the Obesity Society. The articles will appear in the October 27 print issue of JAMA.
A new study reveals the mechanism by which a genetic mutation linked with Parkinson's disease (PD) renders dopamine neurons particularly vulnerable to cell injury and death.
On display at this year's Radiological Society of North America (RSNA) annual meeting, Royal Philips Electronics is highlighting its portfolio in the field of interventional radiology/oncology. The company is developing innovative image-guidance technologies for increasing the range and quality of minimally-invasive interventions and therapies.
› Verified 2 days ago
Dr. John G Schlegelmilch, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5450 | |
Dr. Sherry Ann Guardiano, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5454 | |
Dr. Roy Rajan, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5400 | |
Daniel L Rath, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5400 Fax: 603-354-5429 | |
Dr. Steven Sigurd Larmon, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5454 | |
Dr. Andrew C Gorske, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 590 Court St, Dartmouth Hitchcock - Gastroenterology, Keene, NH 03431 Phone: 603-354-6534 |